{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:26:23Z","timestamp":1774326383839,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jcms.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T18:19:28Z","timestamp":1408558768000},"page":"1932-1936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"42","author":[{"given":"Mihaly","family":"Vaszilko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelin","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Restar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadett","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Cseplo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janos","family":"Kosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2014.08.002_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/mlc.2000.109757","article-title":"Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells","volume":"136","author":"Abe","year":"2000","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jcms.2014.08.002_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/bjc.2012.210","article-title":"Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II\/III breast cancer","volume":"107","author":"Aft","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcms.2014.08.002_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/annonc\/mdl408","article-title":"Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis","volume":"18","author":"Aguiar Bujanda","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2014.08.002_bib3","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2014.08.002_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00774-007-0837-x","article-title":"Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat","volume":"26","author":"Bauss","year":"2008","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.jcms.2014.08.002_bib29","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.295.14.1658","article-title":"Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer","volume":"295","author":"Berry","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jcms.2014.08.002_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/1043-2760(90)90030-7","article-title":"Parathyroid hormone- receptor interactions","volume":"1","author":"Caulfield","year":"1990","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jcms.2014.08.002_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/annonc\/mds277","article-title":"Zole- dronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results","volume":"2","author":"Coleman","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2014.08.002_bib7","first-page":"2","article-title":"The vitamin D system","volume":"29","author":"DeLuca","year":"1990","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jcms.2014.08.002_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.intimp.2006.09.009","article-title":"Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells","volume":"7","author":"Deng","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jcms.2014.08.002_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2014.08.002_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S8756-3282(98)00033-7","article-title":"Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in\u00a0vitro and promote early osteoblastogenesis in young and aged mice in\u00a0vivo","volume":"22","author":"Giuliani","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2014.08.002_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcms.2014.08.002_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14219\/jada.archive.2008.0017","article-title":"Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial","volume":"139","author":"Grbic","year":"2008","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2014.08.002_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00000421-200212001-00002","article-title":"Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis","volume":"25","author":"Green","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jcms.2014.08.002_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2014.08.002_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0952-3278(97)90508-1","article-title":"Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1","volume":"56","author":"Igarashi","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jcms.2014.08.002_bib16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2014.08.002_bib18","first-page":"88","article-title":"Aj\u00e1nl\u00e1s az \u00e9letkorral j\u00e1r\u00f3 osteopor\u00f3zis gy\u00f3gyszeres kezel\u00e9s\u00e9re","volume":"68","author":"Lakatos","year":"2003","journal-title":"Ca \u00e9s Csont"},{"key":"10.1016\/j.jcms.2014.08.002_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (AREDIA) and Zoledronate (ZOMETA) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2014.08.002_bib20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2014.08.002_bib21","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2009-0115","article-title":"Bisphosphonates and time to osteonecrosis development","volume":"14","author":"Palaska","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jcms.2014.08.002_bib22","first-page":"25","article-title":"Hormone sensitivity of tumor in women with breast cancer","volume":"46","author":"Pesic","year":"2007","journal-title":"Acta Med Medianae"},{"key":"10.1016\/j.jcms.2014.08.002_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw. Who gets it and why?","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2014.08.002_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.jcms.2014.08.002_bib25","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2014.08.002_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2004.11.097","article-title":"Mechanisms of sex steroid effects on bone","volume":"328","author":"Syed","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcms.2014.08.002_bib27","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.24119","article-title":"Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients","volume":"115","author":"Walter","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2014.08.002_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study","volume":"66","author":"Wessel","year":"2008","journal-title":"J\u00a0Oral Maxillofac Surg"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518214002443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518214002443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:32:39Z","timestamp":1760884359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518214002443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1010518214002443"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2014.08.002","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}